Millendo Therapeutics Inc

MLND NASDAQ
10.76
-0.32
-2.89%
Opening 14:54 07/17 EDT
Open
11.11
Prev Close
11.08
High
11.33
Low
10.74
Volume
23.24K
Avg Vol (3M)
57.16K
52 Week High
17.34
52 Week Low
6.77
% Turnover
0.17%
Market Cap
144.03M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Millendo Therapeutics Inc MLND stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Millendo Therapeutics, Inc., formerly OvaScience, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing novel treatments for orphan endocrine diseases. The Company is focused on advancing two product candidates to treat three indications. Its advanced product candidate, livoletide (AZP-531), is a potential treatment for Prader-Willi syndrome (PWS), which is a rare and complex genetic endocrine disease characterized by hyperphagia, or insatiable hunger. It is also developing nevanimibe (ATR-101) with a primary focus on treating patients with classic congenital adrenal hyperplasia (CAH), which is a rare, monogenic adrenal disease that requires lifelong treatment with exogenous cortisol.
MORE >

Recently

Name
Price
%Change